SCHORNO DEAN L (EVP &Chief Financial Officer) received a stock award from RIGEL PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2026ACC: 0000905148-26-000952
Officer· EVP &Chief Financial Officer
Since Jan 2019
+20.64K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
20.64K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20.64K
Price / share
—
Trade value
—
% of position
37.0%
2/17/2026
55.70K→76.34K
Total
Net shares
+20.64K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | A · Award | +20.64K | — | — | 37.0% | 55.70K | 76.34K |
| Total | +20.64K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported